Pandemic-Affected Trials Will Need Same Exploratory Analyses That US FDA Used To Save Aducanumab

 
• By Sue Sutter
  
Shipwreck view from above
FDA said it was important to salvage as much information as possible from the terminated Phase III program. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers